Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Sep 2015. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
94013101000001112 | Empagliflozin 5mg / Metformin 1g tablets (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
94013201000001117 | Empagliflozin 5mg / Metformin 1g tablets | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Empagliflozin 5mg / Metformin 1g tablets 60 tablet | Has VMP | True | Empagliflozin 5mg / Metformin 1g tablets | Inferred relationship | Existential restriction modifier | |
Synjardy 5mg/1000mg tablets (CST Pharma Ltd) | Is a | True | Empagliflozin 5mg / Metformin 1g tablets | Inferred relationship | Existential restriction modifier | |
Synjardy 5mg/1000mg tablets (Boehringer Ingelheim Ltd) | Is a | True | Empagliflozin 5mg / Metformin 1g tablets | Inferred relationship | Existential restriction modifier | |
Empagliflozin 5mg / Metformin 1g tablets 56 tablet | Has VMP | True | Empagliflozin 5mg / Metformin 1g tablets | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets